M82 Stock Chart & Stats
€2.74
-€0.02(-0.69%)
At close: 4:00 PM EST
€2.74
-€0.02(-0.69%)
Day’s Range― - ―
52-Week Range€2.42 - €3.22
Previous CloseN/A
Volume0.00
Average Volume (3M)567.00
Market Cap
€4.44B
Enterprise Value€8.55K
Total Cash (Recent Filing)€274.40M
Total Debt (Recent Filing)€1.75B
Price to Earnings (P/E)34.5
Beta0.43
Next Earnings
Aug 27, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding1,451,257,700
10 Day Avg. Volume50
30 Day Avg. Volume567
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.22
Price to Sales (P/S)44.25
P/FCF Ratio11.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.97Price Target Upside8.23% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)0.17
Revenue Forecast (FY)€116.03M
Bulls Say, Bears Say
Bulls Say
Strengthening Cash Generation And Free Cash FlowMaterial improvement in operating and free cash flow in 2025 strengthens the company’s ability to fund distributions, refinance maturing debt, and finance modest growth. Improved cash conversion reduces reliance on external funding and supports the 90%–110% FCF payout policy despite periodic volatility.
Resilient High EBITDA Margin And Traffic At Key AssetsA consistently high ~75% EBITDA margin reflects toll-road pricing power, low incremental operating cost structure, and contractual escalation mechanisms. Combined with strong traffic (eg. Dulles +8.2%), this underpins durable cash flows and operating leverage over the medium term.
Manageable Leverage And Available LiquidityModerate and improving leverage, a sizable equity base and year-end corporate cash ($151m) plus demonstrated bond market access ($1.4bn priced) provide financial flexibility to refinance, absorb shocks and pursue targeted growth without immediate balance-sheet stress.
Bears Say
French Temporary Supplemental Tax (TST) Reducing Cash FlowsThe extended TST is a structural headwind to euro-denominated asset earnings and distributions from France, directly lowering cash received and equity-accounted profits. Its extension into 2026 creates ongoing pressure on corporate receipts and could force payout or investment trade-offs while policy remains uncertain.
Inconsistent Underlying Operating ProfitabilityPersistent negative EBIT in many periods and volatile margins indicate core operations sometimes fail to cover fixed costs, making reported net income reliant on non-operating items or accounting effects. That undermines the stability of distributions and increases sensitivity to traffic or cost shocks.
Regulatory And Concession Uncertainty In FrancePolicy signals toward shorter concessions, smaller perimeters and tougher regulation threaten future contract economics and asset valuations in France. This structural regulatory risk could force renegotiation, lower returns on renewal or increased competition at retendering, impairing long-term cash generation.
Atlas Arteria News
M82 FAQ
What was Atlas Arteria’s price range in the past 12 months?
Atlas Arteria lowest stock price was €2.42 and its highest was €3.22 in the past 12 months.
What is Atlas Arteria’s market cap?
Atlas Arteria’s market cap is €4.44B.
When is Atlas Arteria’s upcoming earnings report date?
Atlas Arteria’s upcoming earnings report date is Aug 27, 2026 which is in 41 days.
How were Atlas Arteria’s earnings last quarter?
Atlas Arteria released its earnings results on Feb 25, 2026. The company reported €0.18 earnings per share for the quarter, missing the consensus estimate of €0.183 by -€0.002.
Is Atlas Arteria overvalued?
According to Wall Street analysts Atlas Arteria’s price is currently Undervalued.
Does Atlas Arteria pay dividends?
Atlas Arteria does not currently pay dividends.
What is Atlas Arteria’s EPS estimate?
Atlas Arteria’s EPS estimate is 0.1.
How many shares outstanding does Atlas Arteria have?
Atlas Arteria has 1,451,257,700 shares outstanding.
What happened to Atlas Arteria’s price movement after its last earnings report?
Atlas Arteria reported an EPS of €0.18 in its last earnings report, missing expectations of €0.183. Following the earnings report the stock price went up 7.598%.
Which hedge fund is a major shareholder of Atlas Arteria?
Currently, no hedge funds are holding shares in DE:M82
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Atlas Arteria Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€2.97 (8.23% Upside)
€2.97 (8.23% Upside)
Blogger Sentiment
Neutral
DE:M82 Sentiment 50%
Sector Average 62%
Sector Average 62%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.72%
12-Months-Change
Fundamentals
Return on Equity
3.46%
Trailing 12-Months
Asset Growth
-0.17%
Trailing 12-Months
Company Description
Atlas Arteria
Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the 22-kilometer Dulles Greenway toll road, situated in Virginia, United States. The company was established in 2009 and operates from its corporate headquarters in Melbourne, Australia. It formally rebranded from Macquarie Atlas Roads Limited to its current name, Atlas Arteria Limited, in May 2018.
M82 Stock 12 Month Forecast
Average Price Target
€2.97
▲(8.23% Upside)
Technical Analysis
Qube Holdings
―
Brambles
―
Aurizon Holdings
―
Transurban Group
―
Dalrymple Bay Infrastructure Ltd.
―